Dublin-headquartered Mallinckrodt is taking over smaller rival Endo and planning to list the combined firm on the New York ...

Mallinckrodt and Endo , drugmakers with a shared history of facing U.S. opioid litigation, have agreed to merge in a deal ...

Mallinckrodt Pharmaceuticals and Endo Inc. are exploring a potential merger that could be valued at about $7 billion, people ...

Mallinckrodt and Endo are exploring a potential merger that could be valued at about $7 billion, person familiar with the ...

Endo shareholders will get $80 million in cash and own 49.9 per cent of the combined company, while Mallinckrodt shareholders ...

Investors looking for safe havens in a dangerous market. China EV players, FedEx and Micron earnings next week.

Despite a rocky start for many drugmakers at the start of last year, 2024’s fourth quarter saw just two of the top 25 global ...

In their own responses to the senators’ inquiries last fall, both Pfizer and Lilly emphasized the independence of their ...

Hogan Lovells, Paul Weiss and Ireland's Arthur Cox and A&L Goodbody also act in tie-up of drugmakers with shared history of ...

The drugmakers, which both emerged from bankruptcies and faced litigation tied to the US opioid crisis in recent years, are discussing the terms of a transaction that would give each company’s ...